Exact Mass: 321.0153052
Exact Mass Matches: 321.0153052
Found 109 metabolites which its exact mass value is equals to given mass value 321.0153052,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clopidogrel
Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. -- Wikipedia; Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. It is also marketed in the generic form by Apotex, a large Canadian generic pharmaceutical company, though an injunction to withhold further shipments of their form is in effect while patent issues are dealt with. In 2005 it was the worlds second highest selling pharmaceutical with sales of US$5.9 billion. [HMDB] Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. -- Wikipedia; Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. It is also marketed in the generic form by Apotex, a large Canadian generic pharmaceutical company, though an injunction to withhold further shipments of their form is in effect while patent issues are dealt with. In 2005 it was the worlds second highest selling pharmaceutical with sales of US$5.9 billion. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Equol 4'-sulfate
C15H13O6S (321.04328180000005)
4-Iodo-2,5-dimethoxyphenylisopropylamine
Lopirazepam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
7-oxohernangerine
An oxoaporphine alkaloid that is 7H-dibenzo[de,g]quinolin-7-one substituted by a methylenedioxy group across positions 1 and 2, a methoxy group at position 11 and a hydroxy group at position 10. Isolated from Hernandia nymphaeifolia and Lindera chunii, it exhibits activity against HIV-1 integrase.
Clopidogrel
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS INTERNAL_ID 2284; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 2284 CONFIDENCE standard compound; INTERNAL_ID 8531 Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
(4-Bromo-2-fluorophenyl)(piperidin-4-yl)Methanone hydrochloride
C12H14BrClFNO (320.99312560000004)
2-amino-3-nitro-6-phenyl-4-thiophen-2-ylbenzonitrile
1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens
Methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate
DIMETHYL 2-(2-NITRO-4-(TRIFLUOROMETHYL)PHENYL)MALONATE
[3-(1,3-benzoxazol-2-yl)-2-oxochromen-7-yl] acetate
5-BROMO-2-(4-METHOXY-PHENYLAMINO)-BENZOIC ACID
C14H12BrNO3 (321.00005020000003)
2-((2-(TRIFLUOROMETHYL)BENZYL)OXY)ISOINDOLINE-1,3-DIONE
C16H10F3NO3 (321.06127460000005)
3-(4-chlorophenyl)sulfonyl-1,3-thiazolidine-2-carbohydrazide
Arsonic acid,[4-[(4-aminophenyl)azo]phenyl]- (9CI)
C12H12AsN3O3 (321.00945820000004)
Benzoic acid,5-[2-[4-(aminosulfonyl)phenyl]diazenyl]-2-hydroxy-
C13H11N3O5S (321.04193960000003)
4-[2,6-dichloro-4-(trifluoromethyl)phenoxy]aniline
2-[(2,4-DICHLOROBENZOYL)AMINO]-4-(METHYLTHIO)BUTANOIC ACID
C12H13Cl2NO3S (320.99931680000003)
N1-(2-BROMOETHYL)-N1-ETHYL-3-METHYLANILINE HYDROBROMIDE
C11H17Br2N (320.97276420000003)
2-(3-Bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylic acid ethyl ester
C12H20BrNO4 (321.0575620000001)
10-(CHLOROACETYL)-2-(METHYLTHIO)-10H-PHENOTHIAZINE
TETRAETHYLAMMONIUM (META)PERIODATE
C8H20INO4 (321.04370300000005)
Methyl 1-(5-bromopyridin-2-yl)-5-cyclopropyl-1H-pyrazole-4-carboxylate
1H-PYRROLO[2,3-B]PYRIDINE-1-SULFONAMIDE, N,N-DIMETHYL-3-(2,2,2-TRIFLUOROACETYL)-
4-[(4-METHYLPHENYL)SULFONYL]-3-NITROBENZOIC ACID
C14H11NO6S (321.03070660000003)
BenzeneMethanol, 3-amino-a-(bromomethyl)-4-(phenylmethoxy)-, (aR)-
5-BROMO-3-TERT-BUTOXYCARBONYLAMINO-THIOPHENE-2-CARBOXYLIC ACID
Naphtho[1,2-d]thiazolium,2-methyl-1-(3-sulfopropyl)-, inner salt
Methyl (2S)-(2-chlorophenyl)(4,7-dihydrothieno[2,3-c]pyridin-6(5H)-yl)acetate
4-(4-Aminophenylazo)phenylarsonic acid
C12H12AsN3O3 (321.00945820000004)
1-([4-((2S)PYRROLIDIN-2-YL)PHENYL]SULFONYL)-4-CHLOROBENZENE
5-Bromoindole-2-boronic acid, pinacol ester
C14H17BBrNO2 (321.05356320000004)
4-Bromo-1h-indole-2-boronic acid pinacol ester
C14H17BBrNO2 (321.05356320000004)
1-(2-Bromo-5-(trifluoromethyl)phenyl)piperidin-2-one
5-(2,4-DICHLOROPHENYL)-4-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL
6-Bromoindole-2-boronic acid pinacol ester
C14H17BBrNO2 (321.05356320000004)
A-BROMO-1-[(1,1-DIMETHYLETHOXY)CARBONYL]-4-PIPERIDINEACETIC ACID
C12H20BrNO4 (321.0575620000001)
2-(N-Methylchloroacetyzamine)-5-chlorobenzophenone
Benzenesulfonamide,4-chloro-N-[3-(dimethylamino)propyl]-3-nitro-
3-Iodo-alpha-methyltyrosine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D019275 - Radiopharmaceuticals
2-({3-[(4-Methylbenzyl)oxy]-2-thienyl}carbonyl)-1-hydrazinecarbothioamide
Ethyl 4-amino-2-[(3-nitropyridin-2-yl)sulfanyl]pyrimidine-5-carboxylate
C12H11N5O4S (321.05317260000004)
(Z)-2-(5-benzylidene-4-oxo-2-thioxothiazolidin-3-yl)-3-methylbutanoic acid
S-[3-(3,4-Dichlorophenyl)-3-oxopropyl]-L-cysteine
C12H13Cl2NO3S (320.99931680000003)
5-[(2-chlorophenyl)methylsulfanylmethyl]-N-cyclopropylfuran-2-carboxamide
Equol 4'-sulfate
C15H13O6S- (321.04328180000005)
Cytidine-monophosphate
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
6-Deoxy-6-sulfo-D-fructose 1-phosphate
C6H10O11PS-3 (320.96814600000005)
Thymidine 5-(hydrogen phosphate)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-[(2,6-dichlorophenyl)methoxy]-2-methyl-1,3-dithian-5-imine
5-bromo-N-[1-(2,5-dimethylphenyl)ethyl]-2-furancarboxamide
2-chloro-N-[5-ethyl-3-[(4-methylphenyl)-oxomethyl]-2-thiophenyl]acetamide
3-[[5-(4-Ethylanilino)-1,3,4-thiadiazol-2-yl]thio]-2-oxolanone
4-chloro-N-[2-fluoro-5-(trifluoromethyl)phenyl]-1-methyl-1H-pyrazole-5-carboxamide
C12H8ClF4N3O (321.02919959999997)
1-[(3,4-Dichlorophenyl)methyl]-3-(oxidoamino)indol-2-ol
4-(3,4-Dichlorophenyl)-5-(4-pyridinyl)-2-thiazolamine
3-CMP(2-)
A nucleoside 3-phosphate(2-) which results from the removal of two protons from the phosphate group of 3-CMP; major species at pH 7.3.
Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl)acetate
cytidine 5-monophosphate(2-)
A pyrimidine nucleoside 5-monophosphate(2-) that results from the removal of two protons from the phosphate group of cytidine 5-monophosphate; major species at pH 7.3.
6-deoxy-6-sulfo-D-fructofuranose 1-phosphate(3-)
C6H10O11PS (320.96814600000005)
An organophosphate oxoanion that is the trianion of 6-deoxy-6-sulfo-D-fructofuranose 1-phosphate; major species at pH 7.3.